Condition
Interstitial Lung Disease Due to Systemic Disease
Total Trials
5
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
P 2 (2)
Trial Status
Recruiting3
Enrolling By Invitation1
Not Yet Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT06195072Phase 2RecruitingPrimary
Platform Clinical Study for Conquering Scleroderma
NCT07345052Recruiting
Western Sweden Systemic Sclerosis Project
NCT05593588Phase 2Enrolling By Invitation
Senolytics Treatment of Interstitial Lung Disease in Common Variable Immunodeficiency
NCT07217093Not Yet Recruiting
Teleconsultation Approach to CTD-ILD Care Delivery in Rural UnderServed CommuniTies (TRUST Initiative)
NCT05365009RecruitingPrimary
Registry of Autoimmune Interstitial Lung Disease
Showing all 5 trials